Ontology highlight
ABSTRACT:
SUBMITTER: Kasner SE
PROVIDER: S-EPMC6701183 | biostudies-literature | 2018 Jun
REPOSITORIES: biostudies-literature
Kasner Scott E SE Lavados Pablo P Sharma Mukul M Wang Yongjun Y Wang Yilong Y Dávalos Antoni A Shamalov Nikolay N Cunha Luis L Lindgren Arne A Mikulik Robert R Arauz Antonio A Lang Wilfried W Czlonkowska Anna A Eckstein Jens J Gagliardi Rubens R Amarenco Pierre P Ameriso Sebastián F SF Tatlisumak Turgut T Veltkamp Roland R Hankey Graeme J GJ Toni Danilo S DS Bereczki Daniel D Uchiyama Shinichiro S Ntaios George G Yoon Byung-Woo BW Brouns Raf R DeVries Basson M M MM Endres Matthias M Muir Keith K Bornstein Natan N Ozturk Serefnur S O'Donnell Martin M Mundl Hardi H Pater Calin C Weitz Jeffrey J Peacock W Frank WF Swaminathan Balakumar B Kirsch Bodo B Berkowitz Scott D SD Peters Gary G Pare Guillaume G Themeles Ellison E Shoamanesh Ashkan A Connolly Stuart J SJ Hart Robert G RG
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20180307 6
<h4>Background</h4>The New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial vs. ASA to Prevent Embolism in Embolic Stroke of Undetermined Source (NAVIGATE-ESUS) trial is a randomized phase-III trial comparing rivaroxaban versus aspirin in patients with recent ESUS.<h4>Aims</h4>We aimed to describe the baseline characteristics of this large ESUS cohort to explore relationships among key subgroups.<h4>Methods</h4>We enrolled 7213 patients at 459 sites in 31 countries. Prespecified su ...[more]